Boehringer’s Slashed Cyltezo Salesforce Reflects Struggles For US Humira Biosimilars

Adoption Of Adalimumab Rivals ‘Has Not Reached Anticipated Potential’

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.